





Medication errors are common through all phases of a hospitalization and represent a significant patient safety risk.  Medication errors lead to Adverse Drug Events which are the most common type of error experienced in a hospital.  Such events represent a significant public health issue and have gained national attention.  Despite this attention, the current financial structure of the United States’ healthcare system inhibits providers from fully embracing efforts to reduce medication errors.
Medication Reconciliation is the act of completing a medication history and correcting discrepancies between a patient’s previous medication regimen and the proposed medication order.  Medication reconciliation characterizes a sustainable solution that can significantly reduce medication errors if performed correctly.  Often, medication reconciliation is performed by a nursing admissions team or physicians, despite the research that proves pharmacists are suited best. When pharmacists perform medication reconciliation it denotes the most effective solution for reducing drug related errors.  
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In 1999, the Institute of Medicine (IOM) report To Err Is Human: Building a Safer Health System identified medication errors as the most common type of health-system error, contributing to thousands of deaths each year. [1] A major source of medication errors are transitions of care, when communication may break down from one provider to another.   As patients are seen by different providers their medications are constantly being altered in frequency and dose, with new medications being added and/or existing medications being omitted.  This problem is becoming increasingly prevalent given the rise of chronic diseases that require treatment from a variety of specialists each of whom prescribes medication.  As the number of handoffs amongst physicians increases, it is becoming increasingly difficult to sustain an accurate and appropriate medication regimen.  
Medication reconciliation is “the process of comparing a patient's medication orders to all of the medications that the patient has been taking.” [2] Medication reconciliation is composed of five steps.  They include developing a list of current medications; developing a list of medications to be prescribed; comparing the medications on the two lists; making clinical decisions based on the comparison; and communicating the new list to appropriate caregivers and to the patient. [2] Nurses, physicians and pharmacists all share responsibility in the medication reconciliation process.  
Although there is shared responsibility across nurses, physicians and pharmacists, very few institutions have effective medication reconciliation processes.  Hospitals have few incentives to create effective programs because of the cost of additional resources and the financing arrangements hospitals face.   Additional barriers to implementation include a lack of communication across providers, disjointed information technology systems, inaccurate medication histories and the complexity of pharmaceuticals.  Despite the lack of a defined process across healthcare institutions, both The Joint Commission and The World Health Organization have made it a goal to reduce the number of medication errors through medication reconciliation and other quality improvement initiatives.  
This essay will consist of a literature review and a case study of an academic medical center Emergency Department’s effort to implement a pharmacist-led medication reconciliation process.  The literature review will evaluate the prevalence and clinical significance of medication errors upon admission, transfer and discharge from a hospital.  It will outline the associated public health outcomes, costs and causes of medication errors as well as the current initiatives and lack of incentives that health organizations face.  The question of the pharmacist’s role in medication reconciliation as a way to address medication errors will be answered.  
The case study will identify the most common types of medication discrepancies in a large academic medical center Emergency Department.  It will summarize the findings of its current medication reconciliation program. In addition to reporting the frequency of medication discrepancies, the case study will examine patient demographic characteristics, sources used by pharmacists and total medication volume among those with and without the discrepancies.  Finally, it will summarize the perspectives of key stakeholders on the barriers of implementing such a program.
1.0 	Literature Review
2.1 Background 	
Google Scholar, PubMed and the University of Pittsburgh’s Library system were used for the collection of all articles.  The World Wide Web provided background information on the regulatory bodies associated with the essay.  The search terms “Adverse Drug Events”, “Costs of Adverse Drug Events”, “Medication Reconciliation”, “Pharmacist-based Medication Reconciliation” and “Computer Physician Order Entry Systems” were among the most commonly used search terms. Referenced publications by Bates et al were used as a supplement source to online searching due to his extensive professional experience in the field of pharmacology.  The literature search was completed from January 1st through March 25th, 2013 and included studies from 1991 to 2012.  
Medication errors can occur at any time during an inpatient stay at a hospital.  Although errors happen across all transitions of care, this paper is focusing on the three most common areas in a hospital, which are during admission, inter-hospital transfers and discharge.  A national survey revealed that hospitals experience a medication error every 22.7 hours (or every 19 admissions) and a medication error that leads to an adverse outcome every 19 days (or every 401 admissions). [29] Hospitals are places where the ill seek care from highly educated professionals.  Most often, these institutions deliver quality services and promote the welfare of communities.  Medication errors are too common within hospitals and represent a critical area that must be addressed.     
   
2.2 Admission
The first step in medication reconciliation according to the Joint Commission is “developing a list of current medications” and thus, should be the basis for any thorough medication reconciliation process. [1] Performing an accurate medication history during an admission may be the most critical step, because this process creates the medication list physicians refer to when making clinical decisions.    
An array of issues may cause patient harm if a proper medication history is not accurately performed during an admission.  The most commonly studied issues are known as an Adverse Drug Events (ADEs).  Under this definition, the term ADE “includes harm caused by the drug (adverse drug reactions and overdoses) and harm from the use of the drug (including dose reductions and discontinuations of drug therapy).” [4] An inaccurate medication history may cause clinicians to overlook the underlying reason for the admission, potential drug-drug interactions and may cause serious injury during a patient’s stay.  Prevalence of drug discrepancies upon admission is high and many studies analyze these errors.  
There are many studies that describe the prevalence and impact of medication discrepancies during an admission.  Two have been selected for the purpose of this essay.    
A comprehensive literature review of 3755 patients in 22 articles, found that 67% of patients experienced a prescription error upon admission.   The most common type of prescribing error is the omission of a medication.  The range of an omission ranged from 10% to 61%, while the range of a commission was 13% to 22%.  The percentage of patients who experience at least one omission or commission error is 60%-67%.  A much higher percentage and lower variability exists when looking at omissions or commissions compared to stand alone events. [6]   
A study by Cornish et al, investigated the prevalence, risk and type of mediation errors.  Through a medication history audit, discrepancies were identified between the physician and pharmacist.   The study was completed over three consecutive months and included 151 patients.   Additionally, the authors analyzed the potential harm that the discrepancies could have caused through a team-based review.  The discrepancies were labeled into three different classes.  Level one discrepancies were classified as those unlikely to cause patient discomfort; level two, as having the potential to cause moderate discomfort or clinical deterioration and level three, as potential to result in severe discomfort or clinical deterioration. [26]
Many notable findings arose from this study including the fact that 53.6%, or 81 out of 151 patients, had at least one medication discrepancy.  Of the 81 patients, a total of 141 discrepancies were identified.  The main discrepancy was the omission of a medication that a patient was taking before admission, with a rate of 46.4%.  Out of the discrepancies discovered, 61.4% were type one, 32.9% were type two and 5.7% were type three. [26] The data collected from this cohort represents the clinical significance of medication errors upon admission by the fact that 38.6% of errors (54 of 141) had the potential to cause moderate discomfort or deterioration to their clinical condition.   
Studies indicate that medication errors upon hospital admission are common.  The most frequently occurring error is one of an omission of a medication. Additionally, there are significant clinical implications associated with an inaccurate medication history.  Many inconsistencies exist in hospital’s medication history taking processes, which is outlined by the high variability in error rates across the published studies.  The omission of a medication is very common and can bring on important clinical implications such as a therapeutic failure or adverse drug withdrawal event.  

2.3 Inter-hospital Transfers 
In a typical tertiary care hospital, there is a Medical ICU, Surgical ICU, Step-Down Units and General Medicine Units.  Usual patient flow patterns involve transfers of care from a Medical ICU/Surgical ICU to a Step-Down Unit and then subsequently to a General Medicine Unit.  Patients who enter the hospital with a severe emergency or surgery will be phased out of an ICU and into a medical unit where they receive an entirely new set of providers.  These handoffs in care represent a large portion of patient volume and are mandatory in many cases.  As providers change so do many clinical interventions, including a patient’s medication regimen.  
One study by Cullen et al supports the finding of a high prevalence of Adverse Drug Events during inter-hospital transfers of care.  
A prospective cohort study by Cullen et al studied 4,031 patients admitted to ICU and general care units in two tertiary care hospitals from February through July 1993.  The study stratified the ICUs in to Surgical and Medical while randomly matching patients from all non-ICU Units (general care).   The purpose of the study was to quantify the rate of both preventable and potential ADEs to gather an understanding of the prevalence in each phase of a hospitalization. [3] Preventable ADEs were defined as an injury caused by a medical injury resulting from a drug.   Potential ADEs were defined as incidents with potential for injury, including drug prescribing and administering errors that were intercepted before the order was actually carried out. [3]  
The study found that there were twice as many ADEs, both preventable and potential, in an ICU compared to a non-ICU Units.  “The combined rate of preventable adverse drug events and potential adverse drug events in ICUs, was 19 events per 1,000 patient days, nearly twice that rate of non-ICUs (10 events per 1,000 patient days).” [3] Upon deeper analysis, the preventable and potential ADE rate was significantly different between the medical ICU, surgical ICU, medical general care unit, and surgical general care units.   The medical ICU rate was 25 events per 1000 patient days, which was higher than the surgical ICU rate of 14 events per 1000 patient days. [3] General Surgical Care Units had 10.8 events per 1000 patient days while General Medical Units had 9.7 events per 1000 patient days.  
Intensity of care is much higher in an ICU than a General Medicine Unit.  An illustration of the intensity is the number of medications being taken by patients in the ICU compared to a General Medicine Unit.  Cullen et al found that patients in ICUs took 15 medications on average compared to a non-ICU average of 9.3.  Once the ADE rates were adjusted for the number of medications taken, there was no difference amongst ICUs and non-ICUs. [3] The number of medications being taken clearly affects the rate of ADEs, however it is important to recognize that patients in ICUs are more susceptible to adverse drug reactions due to their delicate physiological condition.  
An important component to any hospitalization is the communication between providers.  This is especially true given the frequency and operating model that patients experience during a hospitalization.  Overall, the prevalence of ADEs is high amongst all phases of a hospitalization with a range of 9.8 to 25 ADEs per 1000 patient days.  ICUs have a higher rate of ADEs than non-ICUs; however there is no significant difference once risk adjusted for the number of prescriptions being taken.  ICU patients are more susceptible to ADEs because of the high number of prescriptions taken and their decreased physiologic condition.  

2.4 Discharge
Reducing medication errors upon hospital discharge is of utmost importance.  Transition out of a hospital is often a hasty, complex and vulnerable time for a patient.  A patient’s drug regimen often changes from what was prescribed on the inpatient setting to home care.  The patient may be prescribed new medications and thus questions about insurance coverage, cost, and administration may arise.  As a result, patients often experience Adverse Drug Events post hospitalization which may result in harm and readmission.  
A study by Forster et al highlights the impact of medication discrepancies upon discharge from a hospital. 
Forster et al examined the prevalence of Adverse Drug Events post hospital discharge in 400 patients.  The ADE’s were categorized into preventable and ameliorable cases.  A preventable ADE was defined as “being caused by an error in management” and as an ameliorable ADE when “the severity of the event could have been significantly reduced if health care delivery had been optimal.” [27] The study analyzed post hospital outcomes by identifying new or worsening symptoms and utilization of healthcare services through a chart review and telephone interviews.  
Of the 400 patients, 42 had experienced an Adverse Drug Event.  The events were rated as significant in 71% of patients, serious in 13%, and life-threatening in 16%. [27] The ADE was rated “significant if it caused minimal symptoms or it was associated with a low risk of long-term consequences to the patient; serious if it caused a temporary or permanent disability or it was associated with a high risk of long-term consequences to the patient; and life-threatening if it had the potential to lead to a fatality”. [27] These statistics raise two very important points regarding transferring care out of the inpatient setting.  First, the prevalence of drug discrepancies at discharge is abundant, with discrepancies producing an ADE in 11% of the patients.   Second, there are very serious consequences associated with medication errors; 13% of ADE’s caused serious harm and 16% were considered life threatening.   The combination of a high medication error rate and life-threatening consequences puts medication reconciliation at the forefront of patient safety issues post hospitalization.   
In addition to identifying the prevalence of discharge errors, the study was able to underline the need for patient safety efforts.  A chart review separated the data into preventable and ameliorable events.  Out of all the events, 27% were classified as preventable while 33% were ameliorable.  Proving that if a hospital had a more accurate discharge process, 50% of the post-hospitalization ADE’s could have been prevented or the severity of the injury lessened.   A significant correlation was discovered between the number of drugs prescribed and the probability of a patient having an ADE.  There is a need to strengthen the discharge process to reduce the number and severity of Adverse Drug Events.   

2.5 Health Outcomes and Costs	
Studies have quantified the prevalence of medication errors, discrepancies and corresponding Adverse Drug Events during all phases of a hospitalization.  Medication errors are not only a high cause of morbidity and mortality but cost thousands of dollars per episode.
Three studies were identified to express the Morbidity, Mortality, and Costs associated with prescription discrepancies and Adverse Drug Events.  
Morbidity
Drug discrepancies are extremely prevalent in all phases of a hospitalization, including admission, transfers of care and discharge.   Such discrepancies have the potential to cause harm to patients.  This is illustrated by a study by Cornish et al and Forster et al, whom demonstrated 38.6% and 29% of errors, respectively, may cause serious harm to patients.  In the Harvard Medical Practice Study, Lucian Leape examined every type of adverse event that contributed to disabling injuries in 30,195 New York medical records.  Adverse Drug Events were the most common event, contributing to 19% of all adverse events. [4] Drug discrepancies have been demonstrated to influence patient safety and ADE’s make up a substantial portion of all adverse events.  
A study by Classen et al used a matched case control to identify additional length of stay (LOS), increased costs and mortality attributable to ADE’s.   All patients admitted to a Utah hospital from January 1, 1991 to December 31, 1993 were included in the study.  There were 1,580 Cases and 20,197 Controls, which were matched on Diagnosis Related Group (DRG), sex, age, acuity and year of admission.  Morbidity associated with ADE’s was captured by assessing both the crude and attributable length of stay in the case cohort.  The matched control patients had a mean length of stay of 4.46 versus 7.69 days for patients with ADE’s (crude).  In addition, 16.4% of the matched controls spent time in the ICU with an average length of stay of 3.11 days.” [5] Attributable excess length of stay was 1.74 days on average and 3.6 days for cases considered severe.  
A comprehensive study by Phillips et al reviewed 5,309 medication error case reports entered in FDA’s Adverse Event Reporting System from 1993–1998.  The data revealed that 68.2% of the case reports resulted in serious patient outcomes.   A serious patient outcome was defined as “causing death, a threat to life, hospitalization, disability, congenital anomaly or requiring intervention to prevent permanent impairment or damage.” [6] In addition, the elderly population (>60) are the most susceptible to ADE’s because they have more interactions with drugs on average and have heightened sensitivity to pharmacotherapies.  
Mortality
There are numerous ways in which a medication error can lead to patient harm and the prevalence of such events is high.   Beyond being harmful to patients, medication errors can also contribute to unnecessary deaths.   Special attention needs to be given to such events.  
In the study by Phillips et al, 5,309 medication error case reports were reviewed, which revealed that 68.2% resulted in serious patient outcomes.  Of the serious case reports, 9.8% (or 528) were fatal.  The most common type of fatal errors was in patients over sixty years old and the most common type of error was administering an improper dose (40.9%).  The study reviewed only the cases submitted to the FDA, which is large underestimation of the number of medication errors that happen across the country. [6]
Classen et al study established that the difference between crude mortality rates between the control cohort and the case groups were 1.05% and 3.5%, respectfully.  Patients who experienced an ADE had a 3 fold increase mortality rate.  The strongest factor associated with mortality was age.  The elderly, as a percentage of population, will continue to increase in the United States in the years to come and represent the cohort that needs additional attention. [5]  
Costs
“Adverse drug events are injuries that are caused by drugs, such as severe allergic reactions or interactions among medications. Preventable ADEs are injuries that are caused by human error, such as prescribing or administering the wrong dose of a drug.” [7] All ADEs, preventable or not, are associated with excess costs to health systems.  However, preventable ADEs represent an area of opportunity for saving costs, because the main reason for harm is human error rather than a random adverse physiological response.  
A review of 200 charts from six community hospitals between January 1, 2005 and August 31, 2006 was conducted.  A rate of 8.8 per 100 patients had preventable Adverse Drug Events.  The study concluded that the Adverse Drug Events constituted an increase of 4.4 additional hospital days on average.  Although variable, the study cited the average cost of a hospital day at $912.  Therefore, $35,313 in excess cost per 100 patients can be attributed to ADEs.  Medication errors are clearly increasing the price of healthcare in the United States. [7]
A study by Bates et al analyzed costs associated to ADEs and preventable ADEs in a 6 month, case control study of 2 hospitals.  ADEs were identified out of all events that were self-reported by nurses, physician and chart review.  In total there were 190 ADEs in which 90 were classified as preventable.  Risk adjusted regression analysis showed an increase of $3,244 dollars for all ADEs and $5,857 for preventable ADEs. [8] The study also extrapolated these costs to incidence rates of ADEs.  The annual attributable costs of a 700 bed hospital are 5.6 million for all ADEs and 2.8 million for preventable ADEs. [8]  
Adverse Drug events are the most common type of adverse event in the hospital setting.  Morbidity and mortality rates have been shown to be higher in patients experiencing medication related events, while the most vulnerable cohort of patients is the elderly.  Length of stay and likeliness of death are two definitive metrics that highlight these findings.  In addition to increased morbidity and mortality rates, higher costs are also associated with Adverse Drug Events.  Preventable ADEs are the largest opportunity to subdue the effects of such events because they are associated with mistakes in human behavior.    

2.6 Causes of Medication Errors
Medication errors influence the United States’ morbidity and mortality rates while contributing to unnecessary healthcare expenditures.  Medication errors can happen during any phase of a hospitalization and it is clear that improvements in pharmacology management must be made.   Why do so many errors exist in the system and what type of intervention will yield the highest return on investment?  The current financing structure of the healthcare system, frequency of errors in the prescribing phase and the lack of pharmacy utilization by physicians are a few of the many obstacles causing medication errors in the hospital setting.  
Healthcare Financing
The majority of hospital contracts are fee-for-service which doesn’t incentivize hospitals to have quality medication reconciliation processes because they are paid per admission or service.  Hospitals are only responsible for the costs incurred during the hospital stay and not the consequences of any adverse event during or post hospitalization.  Additionally, they lack a reason to coordinate care with providers outside the hospital setting, which includes Primary Care Physicians, nursing homes, etc.  New reimbursement models such as capitation and bundled payments attempt to shift risk onto the provider and promote quality practices.  The Medicare Readmission Reduction Program is an example of a government initiative, which penalizes hospitals for a hospital admission within 30 days of discharge for Acute Myocardial Infarction, Chronic Heart Failure or Pneumonia. [9, 10] Despite the positive aspects of such reimbursement schemes and programs, they are not widespread within the industry.  
Winterstein et al identified the prescribing phase as the most common area for medication errors, citing responsibility 72.5% of the time. [9] Advancements in technology, such as Computerized Physician Order Entry (CPOE) and Clinical Decision Support Systems (CDSS) offer potential solutions to reduce errors by integrating information from a patient’s electronic medical record into the prescribing phase.  The literature on such systems reveals variation on their clinical effectiveness, citing reasons such as overcoming historical processes, IT implementation issues, physician override functions, alarm fatigue, amongst others.  

2.7 Medication Error Reduction Initiatives  
In 2002, the Joint Commission established the National Patient Safety Goals (NPSG) program to help accredited institutions solve common patient safety problems. [17]  In 2005, the Joint Commission made medication reconciliation National Patient Safety Goal number eight; advising health care organizations to accurately and completely reconcile medications across the continuum of care.  Accredited organizations were required to develop and test processes for medication reconciliation to be implemented in 2006. There are two requirements to satisfy the Joint Commission.  The first requirement is to “implement a process for obtaining and documenting a complete list of the patient's current medications upon the patient's admission to the organization and with the involvement of the patient.” [2] The second requirement is “a complete list of the patient's medications is communicated to the next provider of service when a patient is referred or transferred to another setting, service, practitioner or level of care within or outside the organization.” [2] Without satisfying the two requirements, a health system could not achieve the Joint Commission accreditation. National Patient Safety Goal number eight highlighted the lack of defined medication reconciliation process’ that existed within the United States’ healthcare system.  
The Joint Commission’s first attempt at regulating the medication reconciliation process failed due to stringent compliance requirements.  When attempting to measure the effectiveness of goal number eight, the Joint Commission failed to find any uniformity amongst the institutions, leading to a revision in 2011.  “The revised goal sets an expectation for maintaining accurate medication information at critical risk points in the medication use process while allowing organizations latitude to define processes and encouraging performance improvement.” [18] Despite the deregulation, medication reconciliation remains a major patient safety goal for the Joint Commission despite the reduction in requirements set forth.  In July 2011, medication reconciliation was incorporated into National Patient Safety Goal #3, "Improving the safety of using medications." 
In 2005, the World Health Organization (WHO) launched the World Alliance for Patient Safety and developed “Solutions for Patient Safety”. [19] The Joint Commission and Joint Commission International were designated as a WHO Collaborating Centre for Patient Safety Solutions, and were charged with developing and distributing patient safety solutions.   In 2007, the WHO Collaborating Centre for Patient Safety Solutions disseminated nine patient safety solutions to solve shared problems that exist across the world.  The nine solutions are Look-Alike, Sound-Alike Medication Names; Patient Identification; Communication During Patient Hand-Overs; Performance of Correct Procedure at Correct Body Site; Control of Concentrated Electrolyte Solutions; Assuring Medication Accuracy at Transitions in Care; Avoiding Catheter and Tubing Misconnections; Single Use of Injection Devices;  Improved Hand Hygiene to Prevent Health Care-Associated Infection.  Two of the nine safety solutions identified by the World Health Organization revolved around medication safety.  Emphasizing the fact that medication safety issues, specifically “look alike, sound-alike medication names” and “assuring medication accuracy at transitions of care”, are not only U.S. patient safety issues but problems faced around the globe.  
In 2005, the Joint Commission made it a goal to have every healthcare organization perform proper medication reconciliation; however many challenges still arise in this historical approach.   Are pharmacists beneficial to the medication reconciliation process, and if so, is it economically feasible in the Unites States’ healthcare system?

2.8 Effective Medication Reconciliation 
Adverse Drug Events
	Medication reconciliation is correlated to decreased Adverse Drug Events and readmissions in the hospital setting.  A study completed in a Veterans Administration (VA) hospital evaluated the number of adverse drug events decreased with the implementation of a medication reconciliation process.  There was an overall frequency of 0.165 ADEs caused by an admission medication change per admission, in which 50% were due to prescribing errors.  Medication reconciliation was associated with fewer ADEs caused by admission prescribing errors, which was characterized by an adjusted odds ratio of 0.57.  The study characterized the importance of medication reconciliation as a vital aspect in reducing Adverse Drug Events. [28]   
Effective medication reconciliation processes are the most important action a hospital can master if it wants to reduce the number of Adverse Drug Events and readmissions.  Pharmacists have been trained extensively in the therapeutics, formulation and types of medications.  Their skills in medication management can help hospitals as patients change care settings, in modifying medication regimens, or managing multiple medications prescribed by physicians.  Their knowledge can be extracted to deliver quality patient care services, which makes them a valuable asset to any healthcare organization.   
Pharmacist-Based Medication Reconciliation
Although medication errors happen throughout all phases of a hospitalization, research by Pippens et al found that 72% of medication discrepancies were due to errors taking the preadmission medication history rather than during discharge orders. [22] Additionally, Winterstein et al suggests the most common area is during the prescribing phase.   Therefore if institutions want to solve the high rates of medication errors, they should initially focus on admissions, medication histories and the prescription of medications.   
During an admission either a nurse, physician or pharmacist must take a medication history.  A medication history is the act of creating a list of medications, doses and frequency that a patient is currently taking.  “The Best Possible Medication History involves two steps: a systematic process for obtaining a thorough history of all prescribed and non-prescribed medications by using a structured patient interview, and verification of this information with at least one other reliable source of information (for example, a government medication database, medication vials, a community pharmacy or primary care physician).” [21]
Medication Reconciliation is the act of completing a Medication History and correcting discrepancies between a patient’s previous medication regimen and the proposed medication orders during any phase of hospitalization (admission, inpatient transfer and discharge).  The gold standard of medication reconciliation consists of the Best Possible Medication History (BPMH) and involves collaboration amongst a coordinated care team.  It also involves integration into discharge summaries, medication counseling and coordination with post-discharge activities. [21]  
Historically, nurses, physicians and pharmacists have shared responsibility in managing a patient’s medication regimen.  Nurses are responsible for gathering a patient’s medication history and physicians alter the medication regimen as they see fit.  Pharmacists are there to advise physicians on medication uses, side effects and possible interactions.  Nursing education does not properly prepare nurses for the many challenges involved in medication management like prescription forms, dosage strengths, administrative differences, or contraindications.  Additionally, physicians may not fully understand the scope or clinical significance of drug-drug interactions and therefore may not be confident enough to alter a patient’s medication regimen outside their area of expertise.  Pharmaceuticals are a specialty science and the responsibility between nurses, physicians and patients creates a significant safety risk.  Pharmacists are trained in prescription management and therefore may provide the missing link in merging pharmaceutical knowledge into clinical practice.
Many studies have showed the need for a more accurate medication history process by examining the prevalence of medication errors.  Despite the publishing of this data, the question of how the errors happened, and whether they can be prevented, has yet to be answered.  Various studies have shown that pharmacists can perform accurate medication histories; however it is common practice for hospitals to employee nursing teams or have the admitting physician perform medication histories.  The main reason being the high costs associated with hiring additional pharmacists.  
Two studies were found to provide evidence on the effectiveness of pharmacist-	based medication reconciliation
An eight week pilot study by Hayes et al determined the effectiveness of a pharmacist based medication history process. [24] By using the compliance rate of a standard medication reconciliation form used by a Massachusetts hospital, the effectiveness of the current processes and a pharmacist based method was calculated.  It was hospital policy for the admitting physician to perform the medication history and complete the form for every patient admitted through the emergency department. The study retrospectively reviewed four weeks of forms filled out by the admitting physician which comprised the “control group”.  Then during the next four weeks, a pharmacist performed the medication history forms which comprised the “study group”.  A comparison was made between the physician and pharmacist based medication histories.  
The study illustrated a large difference in compliance rates, regarding the actual completion of the form, despite it being hospital policy.  Only 78%, or 78 out of 100 patients, in the control group used the medication reconciliation form, while the study group had a 100% compliance rate. [24] Patients without a completed form are undoubtedly more susceptible to ADEs during their inpatient stay.  Additionally, this difference highlights the efficacy of the hospital policy and gauges the priorities of the admitting physician.  
In addition to analyzing the compliance rate, the completeness of the form was measured by comparing the error rate between the study and control groups.  “A total of 117 errors were identified on the forms in the control group, compared with only 2 errors for the study group.” [24] Additionally, the number of errors per form was higher in the study group and the percentage of forms containing at least 1 error was significantly higher in the control group (59%) than in the study group (3%). [24]
Out of the 117 total errors identified in the control group, 71% were considered errors of incompleteness. “Common errors included missing dose (24%), missing route (21%), missing allergy information (14%), missing schedule (12%), as-needed order with no indication (12%), incorrect dose (8%), and incorrect dosage form (5%).” [24] Another significant finding is that 21% of patients in the control group did not have documented allergies versus 0% of the intervention group. There were no differences in the number of non-formulary drugs ordered by each cohort.  
More common than physicians performing medication histories upon admission is the use of a nursing team.  In an attempt to ease the transition from the emergency department to a hospital unit, hospitals employ nursing admission teams.  One of the main responsibilities of the nursing admission team is to perform an accurate medication history.  By providing a nursing team to focus on medication histories, hospitals hoped to have an accurate medication list.  However, there are several shortfalls in this approach, which include educational and training differences.  
A study published by Nester et al evaluated the differences between a large hospitals typical medication reconciliation process, as performed by an admission nursing team, with that of a pharmacist.  “Patients were alternately assigned to either the control or study group until 50 medication histories had been completed for each group.” [25] The control group consisted of the medication history forms completed by a nurse, which was the typical methodology for the hospital.  The study group was comprised of either a pharmacist or pharmacy student and took medication histories within two hours of an admission.   One hundred patients were enrolled and discrepancies across cohorts were identified.  
Patients in the control group (nursing-led medication reconciliation) were less likely to have a clinical intervention than those enrolled in the study group; 34 patients in the study group were identified as needing at least one intervention compared to 16 identified in the control group.  In addition, compared with nurses, pharmacists identified more patients as taking herbal preparations or nonprescription medications (98% versus 70%). [25] Both of these statistics are of significant importance considering the medication history’s role in reducing ADEs.  Identifying the need for a clinical intervention positively affects a patient’s safety during their inpatient stay.  Concurrently, herbal preparations and nonprescription medications, although typically stopped during a hospital stay, can still produce a negative drug -drug interaction post discharge.  
Other important findings were identification of route or dosage discrepancies, incomplete or missing orders, therapeutic duplications, drug interactions, vaccines recommended, adverse drug interactions and allergy contraindications.  In total, 30 errors were identified by the study group versus 11 in the control group.  In all categories, pharmacists out performed nurses in identifying medication discrepancies except for identifying adverse drug reactions.  This represents an important caveat because every person, regardless of their education, is prone to making mistakes. [25]
It is important to recognize both the clinical and cost benefits associated with a pharmacist based medication reconciliation process.  Karnon et al used an economic model to estimate the baseline of medication errors in the United States and compared it to 5 different methods (studies) that tried to reduce the medication errors originated from an admission to a hospital.  The studies were pharmacist-based medication reconciliation, standardized pharmacy forms, nursing based medication reconciliation, computerized assessments and current medications faxed from the patient’s primary physician.  All five studies were cost effective comparative to the economic baseline.  The study that used a pharmacist based medication reconciliation process was in fact the most cost effective. [24]  

Best Practices Effective Medication Reconciliation
	A number of studies have evaluated the prevalence of medication errors and the negatively correlated patient outcomes.  Numerous studies identify best practices to reduce medication errors within a hospital setting.  However, there is no national standardization of the process and many institutions have been left to solve the problems themselves through trial and error. One institution and its respective program have been reviewed to provide a successful example.
	At the University of Utah Hospitals and Clinics, patients are admitted, pharmacists (and pharmacy interns) perform medication reconciliation and consequently document this process in an electronic health record. The pharmacy team reaches out to outside sources, including community pharmacies to ensure an accurate history.  The pharmacists are part of an inpatient interdisciplinary care team, who monitor patients throughout the hospital stay. 
As patients are discharged, the team coordinates the patient’s medications with the discharge services team. During discharge medication reconciliation, the admission medication list is used as a baseline to determine completeness, accuracy, and appropriateness of discharge orders. The pharmacist will then contact the provider if there are any potential medication issues and meets with each patient prior to discharge.  They then review their medications and provide a complete medication list. As a part of this process, the pharmacy can provide bedside delivery of medications, which enhances patient compliance.  
	During the discharge process the pharmacist will write a note in the electronic health record (EHR) for the next provider.  A team will identify patients through discharge records and follow up via phone call to address any post-hospitalization needs.  A follow up appointment is scheduled with the pharmacist before the primary care visit to provide an opportunity for medication education and recommendations for those patients considered high risk. 
The EHR is an integral part of the medication reconciliation process.  The EHR exists for both inpatient and outpatient, making it important for the currency and accuracy of all health information. Other forms of communication are still prevalent which include paper medication reconciliations provided by the discharge pharmacists and provider-to-provider letters.  Both of which are sent from inpatient to outpatient and from outside clinics to primary care providers. The number of mediums used to transfer medication information makes it difficult to manage, however the one uniform source is the EHR; making it a critical component to providing care across the continuum.  
The University of Utah Hospitals and Clinics have been able to quantify the effectiveness of their medication reconciliation process.  For instance, patients with congestive heart failure (CHF) who were discharged without a pharmacist-conducted medication reconciliation service had a 39% higher chance of readmission.  Overall, 30-day readmission rates decreased from 20.5% to 16.0% when pharmacist-led medication reconciliation was implemented on a full-time basis. [30]

2.9 Summary of Literature Review
Medication Errors are prevalent across all phases of a hospitalization and represent a significant patient safety risk.  In fact, drug-related adverse events are the most common type of adverse event.   Adverse Drug Events play a significant role in hospital morbidity, mortality and avoidable costs.   The most common area that medication errors occur is during the prescription phase.  Thus, significant attention has been given to the use of computerized order entry systems and clinical decision support systems to reduce the rate of the errors.  To date, the efficacy of such software platforms has shown that they may reduce the number of medication errors, but produce mixed results in clinical outcomes.  
Adverse Drug Events have gained both national and international attention as a significant public health issue.  The Joint Commission makes medication reconciliation a requirement for accreditation and the World Health Organization has medication safety as a goal of their Patient Safety Solutions.  Despite these efforts the current financial structure of the United States’ healthcare system inhibits providers from fully embracing efforts to reduce medication reconciliation.  Bundled payments and capitation shift risk onto the provider which may incentivize them to pursue efficient medication reconciliation practices.  





Medication errors plague the United States Health System and many organizations cannot justify the necessary resources needed to correct this issue.  Hospitals represent a significant resource to the community and are held in high regard for their ability to treat a wide variety of diseases of varying severity.  The Emergency Room is a major source of entry into hospitals and is an effective way to receive quality services.  As such, a paradox exists in the fact that the Emergency Room is often the first phase in which post-hospitalization instructions originate (through an accurate medication history process), however it is often a hasty environment filled with clinicians trained to care for a patient’s acute needs only.  This paradox needs to be explored further if hospitals are going to start to align their acute care services with that of a patient’s post-hospitalization needs.  

3.1 Background
UPMC operates 23 academic, community, and specialty hospitals locally and has a large and growing international services division.  It owns over 400 outpatient sites and employs more than 3,200 physicians.  Additionally it offers a range of post-acute services such as retirement and long-term care facilities.  




The admission nursing team was given a number of medication history presentations and 20 “quick tip” reference sheets from a pharmacist.  There were 12 educational presentations over two years which were the first efforts to increase the efficacy of the medication history taking process.  The presentations covered areas such as best practice for taking medication histories, obtaining accurate medication histories upon admission, a guide to insulin, and Asthma/COPD medications.  The reference sheets were to be used by the nursing team at the point of care and contained important information on clinically relevant medications.

Presentations
 1	Best Practice for Taking a Comprehensive Medication History
2	Obtaining Medication Histories at Admission
3	A Guide to Insulin
4	OTC Medication Entry
5	Asthma/COPD Medication Entry
6	OTC and Herbal Medication Entry
7	Utilizing Drug Information Resources
8	Drug Withdrawal
9	Self-Care: OTC Heartburn Agents
10	 Heart Failure Agents and Entry
11	Anti-seizure Medications







1	Local Rx list (24 hr Rx)








10	Calcium + D 
11	Insulin 
12	Asthma and COPD Medications
13	Nasal Sprays for Allergic Rhinitis
14	OTC Acid Reducer Medications
15	OTC Constipation Medications
16	OTC Analgesic and Inflammation/Combination Medications




Figure 2: Reference Sheets
The presentations covered all areas of medication reconciliation, which included performing a comprehensive medication history, prescription medications for chronic diseases, over the counter medications and supplements.  Concurrently, the reference sheets provided help for nurses as they were completing the medication histories.  
Pharmacist Based Medication Reconciliation
Supplementary to educating the nursing department, a pharmacist and two pharmacy students were stationed in the Emergency Department during weekdays with dayshift hours.  The pharmacist or student reviewed the medication history forms completed by the nursing admissions team.   If a discrepancy was found, it was amended and recorded by the pharmacist.  If a pharmacist was not present, nursing-based medication reconciliation resumed. 

3.3 Data Collection
The data in this study consisted of information collected on each patient seen by the pharmacist (or pharmacy student) and the nursing admissions team on February 28th, March 1st, 4th, 5th, 7th, 8th, 11th, 12th and 14th between the hours of 10:30 am to 6:00 pm.  Demographics on every patient were collected which included the sex, age, number of medications (after reconciled), marital status, insurance coverage, the number of previous admissions within one year and the patient’s retail pharmacies.  If a discrepancy was found the type of error was recorded along with the source of the correction.  
Types of discrepancies collected included omitted drugs, wrong drugs, dosing errors, frequency errors, entry errors and duplicate errors.  An omitted drug would be a medication that a nurse failed to include on a patient’s medication history form when the patient is taking the medication.  To be classified a wrong drug error a nurse would have improperly recorded a medication onto the patient’s medication history form while a dosing error would be the improper recording of the medication’s strength.  Incorrect labeling of the number of times a patient is to take a medication is considered a frequency error.  For example, a nurse documented that Tylenol should be taken daily when it should be taken twice a day.  If a nurse were to enter a medication onto the medication history form incorrectly it was labeled as an entry error, while a duplicate error is when a single medication is recorded twice.  
As the pharmacist verified the medication history forms completed by the nursing staff they used the patient, family, home pharmacy, pill bottles, outpatient notes, a patient’s chart and/or Primary Care Physician.  Often times the patient and family could provide enough information to complete a medication history form correctly however it is crucial for the pharmacist/nurse to use alternative sources.  
As previously mentioned, the nursing team had to double source all the medication history forms.  Medication history forms were completed by the nursing admissions team and reviewed by a pharmacist or pharmacy student.  All patients seen by the nursing admissions team were recorded while the discrepancies were categorized and amended. The primary outcome was the occurrence of medication discrepancies as ascertained by a review of a pharmacist and pharmacy students.
In order to establish an understanding of the feasibility of such a program informal interviews were conducted with key clinicians and administrators.  Interviews were conducted with a clinical pharmacist, a pharmacy administrator, the Director of Capacity Management and a Hospital Vice President.  These conversations involved questions about the core communication issues, repeat errors, frustrations and barriers to learning.  All of which laid the groundwork for the fundamental issues with the operation of a medication reconciliation process.  
  
3.4 Analysis
A total of 56 patients had their medication histories completed by a nursing team and subsequently reviewed by a pharmacist over the nine day period.  Of the 56 patients, one person was excluded because they didn’t have any medications at the time of ED arrival and 39 (or 71%) had discrepancies uncovered by a pharmacist.  In total, there were 115 errors, ranging from 1 to 8 per person.  The mean number of discrepancies per person was 2.9 while the median was 2.  The frequencies of errors were as follows: Omission of a medication (24%), entry error (23%), wrong drug (22%) dose errors (16%), frequency errors (14%), and duplications (1%). 

Figure 3: Frequency of Drug Related Errors

The pharmacist was able to use a variety of sources to correct errors.  In total, 89 sources were used to correct all the discrepancies found amongst the 39 patients.  This correlated to a mean 2.3 and a median of 2 sources per patient. The source frequencies are as follows: patient (38%), community pharmacy (28%), outpatient notes (14%), family (10%), medication lists (3%), patient’s chart (4%), pill bottles (3%) and PCP office (0%).   

Figure 4: Frequency of Medication History Sources
The data was also stratified by those in which the pharmacy found discrepancies and those they did not find discrepancies.  The demographics between the two cohorts are represented in the table below.  Notable findings include differences in marital status, percentage with one readmission within the year and the number of medications.

Figure 5: Patient Demographics
   
3.5 Limitations
In total, 56 patients were seen by the pharmacist of pharmacy student over a 9 day period.  The capture rate of the pharmacist intervention was unable to be obtained.   The study was not completed under the strictest of parameters and often times the pharmacist or pharmacy student was unable to staff the ED for the entire 8 hour shift due to presentations or other engagements.  Additionally, this data was collected when the nursing team just started to double source their medication histories.  This required significantly more time and would not reflect a strictly pharmacist based intervention nor an established nursing intervention with necessary double sourcing.  

3.6 Discussion
Medication histories are an important step in medication reconciliation and are important in reducing the Adverse Drug Events.  Errors in medication histories can cause unnecessary drug-to-drug interactions, delay necessary treatments and alter prescribing behaviors of physicians.  As such, the objective of this analysis is to understand how well the nursing admissions team is performing.  
The nursing team has been trained through various presentations and given reference sheets to aid them as they perform medication histories.  Despite this comprehensive training and support, the pharmacists had to amend errors on 39 of the 56 patients.  There were 115 errors identified and the average number of errors per patient was 2.9. Improvements need to be made to the medication history taking process.  Historical approaches such as presentations, ad-hoc training, reference sheets, etc. are not sufficient.  In addition, assessments should be conducted and perceptions gathered to ascertain the knowledge base of the nurses to measure the effectiveness of the training materials.    
Omissions, Entry and Wrong Drug errors were the most common type of errors, suggesting a knowledge gap and that additional time be spent with the nursing staff in these areas.  Second to the patient/family, the pharmacist was most likely to use a community pharmacy as a reliable source for obtaining an accurate medication history.  Such findings may indicate that there a language or rhetoric barrier that exists between pharmacists and nurses.  It may be that pharmacists felt more comfortable speaking to other pharmacists to correct medication histories.  Outpatient notes were used very infrequently, which may suggest that the notes are often incomplete or lack the necessary information to complete a medication history.   Concordantly, the patient’s primary care office was the not used at all, suggesting that it is not preferred by the pharmacist and/or it is difficult to reach.  
Conversations with key stakeholders identified two large barriers to implementation.  Firstly, the education and knowledge of the nursing admissions team does not coincide with that of a pharmacist.  Despite the presentations and educational materials the nursing admissions team was exposed to, errors are still extremely prevalent.  Additionally, pharmacists in the Emergency Department have noticed that the same errors are routinely committed and that there is often confusion in the conversations that follow a correction.   Education may play an important role in professional differences as well.  It may be the case that nurses don’t view the act of properly reconciling medications as important as a pharmacist.  Nurses may not be fully aware of the consequences and harm caused by the smallest fraction of medication errors.  Therefore, they put less effort into learning and self-education.  The basis of these issues may be the amount of pharmacology coursework received in their respective curriculums.
Secondly, communication between pharmacists and nurses needs to be improved.  As previously stated the educational differences are the basis of errors and repeat errors, however it also plays an important part in communication between nurses and pharmacists.  Conversations amongst key stakeholders illustrated that both parties get frustrated when working together.  A common complaint amongst the nurses is the time spent speaking with pharmacists or alternative sources.  In cases that medications need to be amended, nurses must spend time on the phone with central pharmacy looking for a solution.  Understanding drug names was also cited as a very common complaint.  Education, knowledge base and communication are areas which need to be further explored and corrected.  

3.7 Conclusion
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